Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancer
Clinical trial NCT00415168 · COMPLETED
Trial details
- NCT number
- NCT00415168
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2009-07-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.